Navigation Links
Sensus Healthcare Announces its Exhibitor Attendance at the 71st Annual American Academy of Dermatology Meeting
Date:2/22/2013

BOCA RATON, Fla., Feb. 22, 2013 /PRNewswire/ -- Sensus Healthcare is proud to announce their exhibitor participation in the 71st Annual American Academy of Dermatology Meeting in Miami Beach, FL on March 1-5, 2013. Visit booth #2701 to learn more about the advanced SRT-100™ superficial radiotherapy platform, featuring SharpBeam™. The SRT-100 offers unique features and benefits providing Dermatologists a non-invasive option for treating their patients who are diagnosed with skin cancer!

(Logo: http://photos.prnewswire.com/prnh/20130222/FL64841LOGO )

We cordially invite all AAD attendees to visit our booth (#2701) at the upcoming 71st Annual Academy of Dermatology Meeting in Miami Beach, FL and rediscover superficial radiotherapy (SRT). We are proud to feature our SRT-100™ non-invasive treatment system and demonstrate the impact it can have on your practice by providing your patients with a non-invasive treatment option while at the same time increasing your productivity and realizing an excellent ROI! "We are very excited by the feedback we are getting from our Dermatology customers. They are experiencing excellent outcomes as their patients are very happy with the results and they feel their investment in the SRT-100 was well worth it," declared Joe Sardano , President/CEO, Sensus Healthcare.    
See you in Miami!

About Sensus Healthcare:  
Sensus Healthcare is the worldwide leader dedicated to Superficial Radiotherapy Technology (SRT). The featured SRT-100 System is the most advanced non-invasive technology used by Dermatologists and Radiation Oncologists throughout the world in treating Basal Cell (BCC) and Squamus Cell (SCC) Carcinomas. The SRT-100 features SharpBeam technology providing the most accurate and safest treatment possible resulting in proven outcomes. Visit our web site to learn more about Sensus Healthcare…………..Taking new aim at treating skin cancer!  www.sensushealthcare.com 

Media Contact: 
Michelle Verina  
Public Relations  
561-922-5808 Ext. *100  
michelle@sensushealthcare.com  


'/>"/>
SOURCE Sensus Healthcare
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
2. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
3. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
4. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
5. Sequenom Announces Participation at the 23rd Annual Piper Jaffray Healthcare Conference
6. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
7. diaDexus, Inc. to Present at the Canaccord Genuity Healthcare Conference
8. ViroPharma to Participate in Two December Healthcare Investor Conferences
9. Celebrating 65 Years of Providing Superior Healthcare Products, Mission Pharmacal Continues to Thrive
10. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
11. Uroplasty to Present at the Oppenheimer 22nd Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... ... and online shopping cart. The new website has been designed to provide ... digital components allow customers to access detailed product information, read educational industry content ...
(Date:12/7/2016)... Hole, Massachusetts (PRWEB) , ... December 07, 2016 , ... Kara Dwyer Dodge grew up ... Richard Dwyer, a third-generation fisherman in Scituate, Mass., found a sea turtle entangled in the ... shore, where the turtle became a minor sensation because no one could remember ever seeing ...
(Date:12/6/2016)... Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQX: SQIDF), today reported ... year ended September 30, 2016. ... , , SQI is ... that develops and commercializes proprietary technologies and products for advanced multiplexed ... of $1.4 million more than tripling prior years revenue. ...
(Date:12/6/2016)... ... 06, 2016 , ... The Osteoarthritis Research Society International (OARSI) ... (FDA) to consider OA as a serious disease. As an organization of professionals ... of OA patients, many of whom may experience progressive disability and decreased quality ...
Breaking Biology Technology:
(Date:11/22/2016)... 22, 2016 According to the new market research ... Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and ... the market is expected to grow from USD 10.74 Billion in 2015 ... between 2016 and 2022. Continue Reading ... ...
(Date:11/21/2016)... 21, 2016   Neurotechnology , a provider ... today announced that the MegaMatcher On Card fingerprint ... for the NIST Minutiae Interoperability Exchange (MINEX) ... mandatory steps of the evaluation protocol. ... test of fingerprint templates used to establish compliance ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to ... for Private Biobanks shows the highest Compounded Annual Growth Rate ... region during the analysis period 2014-2020. North ... of 9.95% followed by Europe at ...
Breaking Biology News(10 mins):